Evolve your laboratory’s capability for molecular testing with the addition of the full Panther Fusion system or add the Panther Fusion module to your existing Panther® system. The Panther Fusion system joins the flexibility of PCR with the power of TMA to give your lab multiple valuable chemistries on a single platform.
Products
Achieve results with hologic technology
Designed to be the fastest, highest resolution breast tomosynthesis system, ever.
At Hologic, we believe that great science delivers meaningful innovation. This mindset lead to the development of the breakthrough that has made MRI-guided vacuum-assisted breast biopsy possible.
Our flagship ATEC vacuum-assisted breast biopsy system is an all-in-one platform designed for use under ultrasound, MRI, stereotactic and 3D™ image guidance.
Our flagship ATEC vacuum-assisted breast biopsy system is an all-in-one platform designed for use under ultrasound, MRI, stereotactic and 3D™ image guidance.
Transition from screening to interventional procedures for optimal system versatility.
The Affirm prone biopsy system employs advanced, proprietary imaging technology to visualize even hard to see lesions. Upgradable to tomosynthesis imaging.
Molecular assays for the detection of chlamydia, gonorrhea, trichomoniasis, herpes and other highly prevalent STIs.
Precision testing, with viral load monitoring and diagnosis for common viruses on the fully automated Panther® system.
The ThinPrep system and Aptima HPV assays help laboratorians and providers Be Sure when it comes to women's health.
The Aquilex system is the only fluid management system designed to optimize the MyoSure procedure.
Hologic offers a wide array of breast biopsy site marking solutions that work seamlessly with our leading biopsy devices.
MammoSite® and Contura® targeted radiation therapy solutions expedite radiation treatment from five to seven weeks to just five days.
The world’s first and only solution to combine vacuum-assisted tissue acquisition, real-time imaging, verification and advanced post-biopsy handling—all in one, integrated system.
The Celero breast biopsy device is the first vacuum-assisted, spring-loaded core device designed for use under ultrasound.
Elite+ Aesthetic Workstation is a high-powered, dual-wavelength system that delivers fast and effective treatments on all skin types.
The Eviva stereotactic breast biopsy system was designed for prone and upright systems to be seamlessly integrated for a compassionate, minimally invasive breast biopsy.
The Fluoroscan Mini C-arm combines maneuverability, image quality and an intuitive 24” HD touchscreen monitor for optimal extremities imaging.
The Horizon DXA System features the latest in technological innovation for osteoporosis assessment, body composition and more.
Icon incorporates laser and optimized pulsed light technologies into one powerful platform to deliver a comprehensive suite of the most popular aesthetic treatments.
Hologic provides a full suite of analytics software to maximize your mammography technology.
Hologic diagnostic instruments answer the molecular testing demands of today’s labs with automation, efficiency and flexibility.
MammoPad breast pads reduce discomfort during mammography for three out of four women.
MonaLisa Touch therapy is an innovative laser treatment that improves gynecologic health.
The MyoSure tissue removal procedure is a hysteroscopic treatment that removes tissue, including fibroids and polyps.
The NovaSure procedure is a simple 5-minute treatment to reduce or stop menstrual bleeding for women with Abnormal Uterine Bleeding (AUB)
Consolidate your PCR testing with a growing menu of Panther Fusion assays on the fully automated Panther Fusion system.
Powerful and accurate tools help healthcare providers determine a woman’s risk for preterm labor to help guide treatment decisions.
PicoSure is the world’s first picosecond aesthetic laser capable of revitalizing skin with virtually no downtime.
SculpSure® non-invasive body contouring treatments safely target fat cells for a slim, natural-looking appearance – in just 25 minutes, without affecting the skin’s surface.
These systems offer flexible and comprehensive interactive diagnostic tools that allow radiologists to read clearly and work more efficiently — paving the way to improved patient care.
The Sertera biopsy device is the newest member of the Hologic ultrasound-guided breast biopsy family.
Our breakthrough breast compression technology – available with our Genius™ 3D Mammography™ exam* – delivers a clinically proven, more comfortable patient experience.
Smartlipo® Triplex® is the gold standard, minimally invasive laser lipolysis procedure that targets troublesome areas to permanently eliminate fat.
The first wireless, handheld breast ultrasound with exceptional breast image quality. Enabling optimization of your clinical workflow and patient pathway — all at an affordable cost.
Our medical technologies drive results
The ThinPrep® Pap test was the first liquid-based cytology option in cervical cancer screening. In more than two decades, the ThinPrep Pap test has contributed to a significant decline in cervical cancer rates.2
References
1. Hologic, Inc. Data on File. 2. National Cancer Institute. SEER Stat Fact Sheets: Cervix Uteri Cancer. http://seer.cancer. gov/statfacts/html/cervix.html. Published 2016. Accessed May 25, 2017.
The world’s first and only solution to combine vacuum-assisted tissue acquisition, real-time imaging, verification and advanced post-biopsy handling –all in one, integrated system.
Reference
1. 2015 Kadence International survey of 200 healthcare professionals.
Our breakthrough breast stabilization system – available only on our Dimensions® family of mammography systems* – delivers a clinically proven, more comfortable patient experience.
Reference
* FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005
1. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00119 Rev 003 (2017).
SculpSure non-invasive body contouring laser treatments safely target and destroy fat cells for a natural-looking, slimmer appearance — in just 25 minutes.
Reference
1. Katz B, Doherty S. A multi-center study of the safety and efficacy of a non-invasive 1060 nm diode laser for fat reduction of the flanks. Paper presented at: 2015 Annual American Society for Laser Medicine and Surgery Conference; April 22-26; Kissimmee, FL.
The MyoSure procedure is simple and efficient, and it can be performed by a doctor in his or her office. The procedure takes between 15-30 minutes to complete – it’s quick!
References and Important Safety Information
1. McIlwaine P, McElhinney B, Karthigasu KA, Hart R, A Prospective Study of the Use of the MyoSure Resectoscope to Manage Endometrial Polyps in an Outpatient Setting. The Australian and New Zealand Journal of Obstetrics and Gynaecology. October 2015.
Important Safety Information: The MyoSure® tissue removal system, consisting of the MyoSure tissue removal devices (LITE, REACH, XL) and MyoSure controller, is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps and retained products of conception. The MyoSure MANUAL tissue removal device is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue. MyoSure products are not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies or previously diagnosed uterine cancer. For more details on risks and benefits of the MyoSure system, MyoSure MANUAL tissue removal device, MyoSure hysteroscope and the Aquilex® fluid control system, please see their respective IFUs.
To date, over 2.5 million women have been treated with the NovaSure procedure.1 For 77.7% of women, menstrual bleeding is successfully reduced or stopped within one year.2
References and Important Safety Information
1. Hologic, Inc. Data on file;2014-2015. 2. NovaSure Instructions for Use.
Important Safety Information: NovaSure® endometrial ablation is for premenopausal women with heavy periods due to benign causes who are finished childbearing. Pregnancy following the NovaSure procedure can be dangerous. The NovaSure procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. NovaSure endometrial ablation is not a sterilization procedure. Rare but serious risks include, but are not limited to, thermal injury, perforation and infection. Temporary side effects may include cramping, nausea, vomiting, discharge and spotting. Inform patients to contact you if they experience a possible side effect related to use of this product. For detailed benefit and risk information, please consult the IFU.